You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)
- Disease
- chronic obstructive pulmonary disease
- Drug Name
- AZD2423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- IIa
- Start Date
- Jan 18, 1971
- Study Name
- D3320C00001
- Study Id
- D3320C00001
- ClinicalTrials.gov ID
- NCT01153321
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
